CL2008002003A1 - Anti-pertussis vaccine component comprising pertactin (prn) of cell membrane protein from bordetella pertussis; Simplified procedure to obtain prn with more than 90% purity. - Google Patents

Anti-pertussis vaccine component comprising pertactin (prn) of cell membrane protein from bordetella pertussis; Simplified procedure to obtain prn with more than 90% purity.

Info

Publication number
CL2008002003A1
CL2008002003A1 CL2008002003A CL2008002003A CL2008002003A1 CL 2008002003 A1 CL2008002003 A1 CL 2008002003A1 CL 2008002003 A CL2008002003 A CL 2008002003A CL 2008002003 A CL2008002003 A CL 2008002003A CL 2008002003 A1 CL2008002003 A1 CL 2008002003A1
Authority
CL
Chile
Prior art keywords
prn
pertussis
pertactin
purity
cell membrane
Prior art date
Application number
CL2008002003A
Other languages
Spanish (es)
Inventor
Jain M L Mago Rajesh
Original Assignee
M S Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by M S Panacea Biotec Ltd filed Critical M S Panacea Biotec Ltd
Publication of CL2008002003A1 publication Critical patent/CL2008002003A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Componente de vacuna anti-pertussis que comprende pertactina (prn) de proteína de membrana celular de bordetella pertussis; procedimiento simplificado para obtener prn con mas de un 90% de pureza.Anti-pertussis vaccine component comprising pertactin (prn) of cell membrane protein from bordetella pertussis; Simplified procedure to obtain prn with more than 90% purity.

CL2008002003A 2007-07-31 2008-07-09 Anti-pertussis vaccine component comprising pertactin (prn) of cell membrane protein from bordetella pertussis; Simplified procedure to obtain prn with more than 90% purity. CL2008002003A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1618DE2007 2007-07-31

Publications (1)

Publication Number Publication Date
CL2008002003A1 true CL2008002003A1 (en) 2008-11-03

Family

ID=40303927

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2008002003A CL2008002003A1 (en) 2007-07-31 2008-07-09 Anti-pertussis vaccine component comprising pertactin (prn) of cell membrane protein from bordetella pertussis; Simplified procedure to obtain prn with more than 90% purity.

Country Status (3)

Country Link
AR (1) AR067471A1 (en)
CL (1) CL2008002003A1 (en)
WO (1) WO2009016651A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2430040A1 (en) * 2009-05-11 2012-03-21 Novartis AG Antigen purification process for pertactin antigen
US10329323B2 (en) 2014-07-25 2019-06-25 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Method for purifying antibodies using PBS
KR102426041B1 (en) * 2017-08-01 2022-07-29 주식회사 녹십자 Method for obtaining bordetella pertussis related protein comprising processes of freezing and thawing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9007657D0 (en) * 1990-04-04 1990-05-30 Connaught Lab Purification of a pertussis outer membrane protein(omp69)
DE69736709T2 (en) * 1996-07-02 2007-10-04 Sanofi Pasteur Ltd., Toronto MANY DTP POLIO VACCINES

Also Published As

Publication number Publication date
AR067471A1 (en) 2009-10-14
WO2009016651A1 (en) 2009-02-05

Similar Documents

Publication Publication Date Title
ECSP10010095A (en) 2'-FLUORO-2'-DEOXITETHYDROURIDINES AS INHIBITORS OF CITIDINE DESAMINASE
CL2008002076A1 (en) Compounds derived from substituted aryloxazoles; process for preparing said compounds; pharmaceutical composition comprising them; and its use to treat diabetes, metabolic syndrome, dyslipidemias, among other diseases.
CL2009000349A1 (en) Compounds derived from 4,5-dihydro-oxazol-2-ylamine; preparation procedure; pharmaceutical composition; and its use for the treatment of Alzheimer's disease.
ECSP099619A (en) ANTI-ROBO4 ANTIBODIES AND THEIR USES
CL2011000527A1 (en) Compounds derived from benzofuran; pharmaceutical composition that includes them; and their use in the treatment of hepatitis c.
AR066042A1 (en) MOLECULES AND METHODS TO MODULATE PROTEIN CONVERTASA-SUBTILISIN / QUEXIN TYPE 9 (PCSK9)
PE20080748A1 (en) VACCINE BASED ON THE NEISSERIA STRAINS
BRPI0611863A2 (en) compound as well as composition and kit comprising the same, intermediate compound in the preparation thereof, method for treatment and use thereof
ECSP12011805A (en) COMPOUNDS
MY139896A (en) Improved prrs vaccines
CR11731A (en) COMPOSITIONS AND PROCEDURES FOR PREPARATION AND USE
CO6321189A2 (en) BENCEN-SULFONAMIDE TIAZOL AND OXAZOL COMPOUNDS
CL2008001879A1 (en) Compounds derived from isaxolines-naphthalene-carboamide; and the use of the compounds in the control of invertebrate pests in animals.
UY30498A1 (en) NEW CLASS OF BENZIMIDAZOLILO COMPOUNDS, ITS SALTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS
GT201000047A (en) IMPROVEMENTS IN ORGANIC COMPOUNDS OR RELATED TO THE SAME
ECSP109968A (en) CYCLIC DEPSIPEPTIDES
GT200900309A (en) DERIVATIVES OF 7-ALQUINIL-1,8-NAFTIRIDONAS, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
UY29149A1 (en) TIAZOLIL-DIHIDRO-INDAZOLES
BRPI0618479A2 (en) pyrrolpyridines pharmaceutical composition containing them
AR059851A1 (en) ANTIBODIES OF EGFL7 AND METHODS OF USE
CL2009000665A1 (en) Pyrrolidinyl derived compounds; pharmaceutical composition comprising said compounds; and its use in the treatment of anxiety, depression or both.
BRPI0606506A2 (en) yersinia spp. polypeptides. and methods of use
EA200701595A1 (en) SUSTAINABLE FOR ALCOHOLS MEDICINE FORMS
CL2008002003A1 (en) Anti-pertussis vaccine component comprising pertactin (prn) of cell membrane protein from bordetella pertussis; Simplified procedure to obtain prn with more than 90% purity.
CO6341474A2 (en) SOLID FORMS OF (1R, 2S, 3R) -1- (2-ISOXAZOL-3-IL) -1H-IMIDAZOL-4-IL) BUTANE-1,2,3,4-TETRAOL AND METHODS FOR USE